Global Adoptive?Cellular?Immunotherapy Professional Survey Report 2021 Forecast to 2026

Code: RW00014533424
Multimarket Insight
Oct-2021
Life Sciences
152 Pages

Adoptive immunotherapy?involves administration of immune effector cells into a patient to produce antitumor effects.?
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Adoptive?Cellular?Immunotherapy industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
TIL
LAK
CAR-T
TCR-T
CIK
NK
DC
Other

Market Segment by Product Application
Hospital
Cancer Hospital
Centers for Disease Control and Prevention
Rehabilitation Center
Other

Finally, the report provides detailed profile and data information analysis of leading company.
Amgen Inc
Celgene Corp
Bellicum Pharmaceuticals Inc
Autolus Therapeutics Plc
CARsgen Therapeutics Ltd
Beijing Immunochina Medical Science & Technology Co Ltd
Cellular Biomedicine Group Inc
bluebird bio Inc
Bristol-Myers Squibb Co
Cell Medica Ltd
Gilead Sciences Inc
Hebei Senlang Biotechnology Inc Ltd
Celularity Inc
Juno Therapeutics Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Fosun Pharmaceutical AG
Celyad SA
HRAIN Biotechnology Co Ltd
Hangzhou Converd Co Ltd
Daiichi Sankyo Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Kite Pharma Inc
Ono Pharmaceutical Co Ltd
Novartis AG
Takara Bio Inc
Nkarta Inc
Nanjing Legend Biotech Co Ltd
Sorrento Therapeutics Inc
NantKwest Inc

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Adoptive?Cellular?Immunotherapy consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Adoptive?Cellular?Immunotherapy market by identifying its various subsegments.
3.Focuses on the key global Adoptive?Cellular?Immunotherapy manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Adoptive?Cellular?Immunotherapy with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Adoptive?Cellular?Immunotherapy submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Adoptive?Cellular?Immunotherapy Professional Survey Report Report 2021, Forecast to 2026

1 Market Study Overview
1.1 Study Objectives
1.2 Adoptive?Cellular?Immunotherapy Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Adoptive?Cellular?Immunotherapy Segment by Type
2.1.1 TIL
2.1.2 LAK
2.1.3 CAR-T
2.1.4 TCR-T
2.1.5 CIK
2.1.6 NK
2.1.7 DC
2.1.8 Other
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Cancer Hospital
2.2.3 Centers for Disease Control and Prevention
2.2.4 Rehabilitation Center
2.2.5 Other
2.3 Global Adoptive?Cellular?Immunotherapy Market Comparison by Regions (2016-2026)
2.3.1 Global Adoptive?Cellular?Immunotherapy Market Size (2016-2026)
2.3.2 North America Adoptive?Cellular?Immunotherapy Status and Prospect (2016-2026)
2.3.3 Europe Adoptive?Cellular?Immunotherapy Status and Prospect (2016-2026)
2.3.4 Asia-pacific Adoptive?Cellular?Immunotherapy Status and Prospect (2016-2026)
2.3.5 South America Adoptive?Cellular?Immunotherapy Status and Prospect (2016-2026)
2.3.6 Middle East & Africa Adoptive?Cellular?Immunotherapy Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Adoptive?Cellular?Immunotherapy Industry Impact
2.5.1 Adoptive?Cellular?Immunotherapy Business Impact Assessment - Covid-19
2.5.2 Market Trends and Adoptive?Cellular?Immunotherapy Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Adoptive?Cellular?Immunotherapy Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Adoptive?Cellular?Immunotherapy Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Adoptive?Cellular?Immunotherapy Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Adoptive?Cellular?Immunotherapy Manufacturer Market Share
3.5 Top 10 Adoptive?Cellular?Immunotherapy Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Adoptive?Cellular?Immunotherapy Market
3.7 Key Manufacturers Adoptive?Cellular?Immunotherapy Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of Adoptive?Cellular?Immunotherapy Industry Key Manufacturers
4.1 Amgen Inc
4.1.1 Company Details
4.1.2 Amgen Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.1.3 Amgen Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Amgen Inc News
4.2 Celgene Corp
4.2.1 Company Details
4.2.2 Celgene Corp Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.2.3 Celgene Corp Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Celgene Corp News
4.3 Bellicum Pharmaceuticals Inc
4.3.1 Company Details
4.3.2 Bellicum Pharmaceuticals Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.3.3 Bellicum Pharmaceuticals Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Bellicum Pharmaceuticals Inc News
4.4 Autolus Therapeutics Plc
4.4.1 Company Details
4.4.2 Autolus Therapeutics Plc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.4.3 Autolus Therapeutics Plc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Autolus Therapeutics Plc News
4.5 CARsgen Therapeutics Ltd
4.5.1 Company Details
4.5.2 CARsgen Therapeutics Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.5.3 CARsgen Therapeutics Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 CARsgen Therapeutics Ltd News
4.6 Beijing Immunochina Medical Science & Technology Co Ltd
4.6.1 Company Details
4.6.2 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.6.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Beijing Immunochina Medical Science & Technology Co Ltd News
4.7 Cellular Biomedicine Group Inc
4.7.1 Company Details
4.7.2 Cellular Biomedicine Group Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.7.3 Cellular Biomedicine Group Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.5 Cellular Biomedicine Group Inc News
4.8 bluebird bio Inc
4.8.1 Company Details
4.8.2 bluebird bio Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.8.3 bluebird bio Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 bluebird bio Inc News
4.9 Bristol-Myers Squibb Co
4.9.1 Company Details
4.9.2 Bristol-Myers Squibb Co Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.9.3 Bristol-Myers Squibb Co Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 Bristol-Myers Squibb Co News
4.10 Cell Medica Ltd
4.10.1 Company Details
4.10.2 Cell Medica Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.10.3 Cell Medica Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.10.4 Main Business Overview
4.10.5 Cell Medica Ltd News
4.11 Gilead Sciences Inc
4.11.1 Company Details
4.11.2 Gilead Sciences Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.11.3 Gilead Sciences Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.11.4 Main Business Overview
4.11.5 Gilead Sciences Inc News
4.12 Hebei Senlang Biotechnology Inc Ltd
4.12.1 Company Details
4.12.2 Hebei Senlang Biotechnology Inc Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.12.3 Hebei Senlang Biotechnology Inc Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.12.4 Main Business Overview
4.12.5 Hebei Senlang Biotechnology Inc Ltd News
4.13 Celularity Inc
4.13.1 Company Details
4.13.2 Celularity Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.13.3 Celularity Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.13.4 Main Business Overview
4.13.5 Celularity Inc News
4.14 Juno Therapeutics Inc
4.14.1 Company Details
4.14.2 Juno Therapeutics Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.14.3 Juno Therapeutics Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.14.4 Main Business Overview
4.14.5 Juno Therapeutics Inc News
4.15 Guangzhou Anjie Biomedical Technology Co Ltd
4.15.1 Company Details
4.15.2 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.15.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.15.4 Main Business Overview
4.15.5 Guangzhou Anjie Biomedical Technology Co Ltd News
4.16 Fosun Pharmaceutical AG
4.16.1 Company Details
4.16.2 Fosun Pharmaceutical AG Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.16.3 Fosun Pharmaceutical AG Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.16.4 Main Business Overview
4.16.5 Fosun Pharmaceutical AG News
4.17 Celyad SA
4.17.1 Company Details
4.17.2 Celyad SA Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.17.3 Celyad SA Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.17.4 Main Business Overview
4.17.5 Celyad SA News
4.18 HRAIN Biotechnology Co Ltd
4.18.1 Company Details
4.18.2 HRAIN Biotechnology Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.18.3 HRAIN Biotechnology Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.18.4 Main Business Overview
4.18.5 HRAIN Biotechnology Co Ltd News
4.19 Hangzhou Converd Co Ltd
4.19.1 Company Details
4.19.2 Hangzhou Converd Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.19.3 Hangzhou Converd Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.19.4 Main Business Overview
4.19.5 Hangzhou Converd Co Ltd News
4.20 Daiichi Sankyo Co Ltd
4.20.1 Company Details
4.20.2 Daiichi Sankyo Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.20.3 Daiichi Sankyo Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.20.4 Main Business Overview
4.20.5 Daiichi Sankyo Co Ltd News
4.21 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
4.21.1 Company Details
4.21.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.21.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.21.4 Main Business Overview
4.21.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd News
4.22 Kite Pharma Inc
4.22.1 Company Details
4.22.2 Kite Pharma Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.22.3 Kite Pharma Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.22.4 Main Business Overview
4.22.5 Kite Pharma Inc News
4.23 Ono Pharmaceutical Co Ltd
4.23.1 Company Details
4.23.2 Ono Pharmaceutical Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.23.3 Ono Pharmaceutical Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.23.4 Main Business Overview
4.23.5 Ono Pharmaceutical Co Ltd News
4.24 Novartis AG
4.24.1 Company Details
4.24.2 Novartis AG Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.24.3 Novartis AG Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.24.4 Main Business Overview
4.24.5 Novartis AG News
4.25 Takara Bio Inc
4.25.1 Company Details
4.25.2 Takara Bio Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.25.3 Takara Bio Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.25.4 Main Business Overview
4.25.5 Takara Bio Inc News
4.26 Nkarta Inc
4.26.1 Company Details
4.26.2 Nkarta Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.26.3 Nkarta Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.26.4 Main Business Overview
4.26.5 Nkarta Inc News
4.27 Nanjing Legend Biotech Co Ltd
4.27.1 Company Details
4.27.2 Nanjing Legend Biotech Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.27.3 Nanjing Legend Biotech Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.27.4 Main Business Overview
4.27.5 Nanjing Legend Biotech Co Ltd News
4.28 Sorrento Therapeutics Inc
4.28.1 Company Details
4.28.2 Sorrento Therapeutics Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.28.3 Sorrento Therapeutics Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.28.4 Main Business Overview
4.28.5 Sorrento Therapeutics Inc News
4.29 NantKwest Inc
4.29.1 Company Details
4.29.2 NantKwest Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.29.3 NantKwest Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.29.4 Main Business Overview
4.29.5 NantKwest Inc News

5 Global Adoptive?Cellular?Immunotherapy Sales Categorized by Regions
5.1 Global Adoptive?Cellular?Immunotherapy Revenue, Sales and Market Share by Regions
5.1.1 Global Adoptive?Cellular?Immunotherapy Sales and Market Share by Regions (2016-2021)
5.1.2 Global Adoptive?Cellular?Immunotherapy Revenue and Market Share by Regions (2016-2021)
5.2 North America Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
5.3 Europe Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
5.4 Asia-pacific Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
5.5 South America Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
5.6 Middle East & Africa Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)

6 North America Adoptive?Cellular?Immunotherapy Market Size Categorized by Countries
6.1 North America Adoptive?Cellular?Immunotherapy Sales, Revenue and Market Share by Countries
6.1.1 North America Adoptive?Cellular?Immunotherapy Sales (Volume) by Countries (2016-2021)
6.1.2 North America Adoptive?Cellular?Immunotherapy Revenue by Countries (2016-2021)
6.1.3 United States Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
6.1.4 Canada Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
6.1.5 Mexico Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
6.2 North America Adoptive?Cellular?Immunotherapy Revenue (Value) by Manufacturers
6.3 North America Adoptive?Cellular?Immunotherapy Sales and Market Share by Type (2016-2021)
6.4 North America Adoptive?Cellular?Immunotherapy Sales Market Share by Application (2016-2021)

7 Europe Adoptive?Cellular?Immunotherapy Market Size Categorized by Countries
7.1 Europe Adoptive?Cellular?Immunotherapy Sales, Revenue and Market Share by Countries
7.1.1 Europe Adoptive?Cellular?Immunotherapy Sales (Volume) by Countries (2016-2021)
7.1.2 Europe Adoptive?Cellular?Immunotherapy Revenue by Countries (2016-2021)
7.1.3 Germany Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
7.1.4 UK Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
7.1.5 France Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
7.1.6 Russia Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
7.1.7 Italy Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
7.1.8 Spain Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
7.2 Europe Adoptive?Cellular?Immunotherapy Revenue (Value) by Manufacturers
7.3 Europe Adoptive?Cellular?Immunotherapy Sales and Market Share by Type (2016-2021)
7.4 Europe Adoptive?Cellular?Immunotherapy Sales Market Share by Application (2016-2021)

8 Asia-Pacific Adoptive?Cellular?Immunotherapy Market Size Categorized by Countries
8.1 Asia-pacific Adoptive?Cellular?Immunotherapy Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Adoptive?Cellular?Immunotherapy Sales (Volume) by Countries (2016-2021)
8.1.2 Asia-pacific Adoptive?Cellular?Immunotherapy Revenue by Countries (2016-2021)
8.1.3 China Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
8.1.4 South Korea Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
8.1.5 Japan Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
8.1.6 Australia Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
8.1.7 India Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
8.1.8 Southeast Asia Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
8.2 Asia-pacific Adoptive?Cellular?Immunotherapy Revenue (Value) by Manufacturers
8.3 Asia-pacific Adoptive?Cellular?Immunotherapy Sales and Market Share by Type (2016-2021)
8.4 Asia-pacific Adoptive?Cellular?Immunotherapy Sales Market Share by Application (2016-2021)

9 South America Adoptive?Cellular?Immunotherapy Market Size Categorized by Countries
9.1 South America Adoptive?Cellular?Immunotherapy Sales, Revenue and Market Share by Countries
9.1.1 South America Adoptive?Cellular?Immunotherapy Sales (Volume) by Countries (2016-2021)
9.1.2 South America Adoptive?Cellular?Immunotherapy Revenue by Countries (2016-2021)
9.1.3 Brazil Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
9.2 South America Adoptive?Cellular?Immunotherapy Sales and Market Share by Type (2016-2021)
9.3 South America Adoptive?Cellular?Immunotherapy Sales Market Share by Application (2016-2021)

10 Middle East and Africa Adoptive?Cellular?Immunotherapy Market Size Categorized by Countries
10.1 Middle East and Africa Adoptive?Cellular?Immunotherapy Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Adoptive?Cellular?Immunotherapy Sales (Volume) by Countries (2016-2021)
10.1.2 Middle East and Africa Adoptive?Cellular?Immunotherapy Revenue by Countries (2016-2021)
10.1.3 GCC Countries Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
10.1.4 Turkey Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
10.1.5 Egypt Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
10.1.6 South America Adoptive?Cellular?Immunotherapy Sales and Growth Rate (2016-2021)
10.2 Middle East and Africa Adoptive?Cellular?Immunotherapy Sales and Market Share by Type
10.3 Middle East and Africa Adoptive?Cellular?Immunotherapy Sales Market Share by Application (2016-2021)

11 Global Adoptive?Cellular?Immunotherapy Market Segment by Type
11.1 Global Adoptive?Cellular?Immunotherapy Revenue, Sales and Market Share by Type (2016-2021)
11.1.1 Global Adoptive?Cellular?Immunotherapy Sales and Market Share by Type (2016-2021)
11.1.2 Global Adoptive?Cellular?Immunotherapy Revenue and Market Share by Type (2016-2021)
11.2 TIL Sales Growth Rate and Price
11.2.1 Global TIL Sales Growth Rate (2016-2021)
11.2.2 Global TIL Price (2016-2021)
11.3 LAK Sales Growth Rate and Price
11.3.1 Global LAK Sales Growth Rate (2016-2021)
11.3.2 Global LAK Price (2016-2021)
11.4 CAR-T Sales Growth Rate and Price
11.4.1 Global CAR-T Sales Growth Rate (2016-2021)
11.4.2 Global CAR-T Price (2016-2021)
11.5.1 Global TCR-T Sales Growth Rate (2016-2021)
11.5.2 Global TCR-T Price (2016-2021)
11.6 CIK Sales Growth Rate and Price
11.6.1 Global CIK Sales Growth Rate (2016-2021)
11.6.2 Global CIK Price (2016-2021)
11.7 NK Sales Growth Rate and Price
11.7.1 Global NK Sales Growth Rate (2016-2021)
11.7.2 Global NK Price (2016-2021)
11.8 DC Sales Growth Rate and Price
11.8.1 Global DC Sales Growth Rate (2016-2021)
11.8.2 Global DC Price (2016-2021)
11.9 Other Sales Growth Rate and Price
11.9.1 Global Other Sales Growth Rate (2016-2021)
11.9.2 Global Other Price (2016-2021)

12 Global Adoptive?Cellular?Immunotherapy Market Segment by Application
12.1 Global Adoptive?Cellular?Immunotherapy Sales Market Share by Application (2016-2021)
12.2 Hospital Sales Growth Rate (2016-2021)
12.3 Cancer Hospital Sales Growth Rate (2016-2021)
12.4 Centers for Disease Control and Prevention Sales Growth Rate (2016-2021)
12.5 Rehabilitation Center Sales Growth Rate (2016-2021)

13 Global Adoptive?Cellular?Immunotherapy Market Forecast
13.1 Global Adoptive?Cellular?Immunotherapy Revenue, Sales and Growth Rate (2021-2026)
13.2 Adoptive?Cellular?Immunotherapy Market Forecast by Regions (2021-2026)
13.2.1 North America Adoptive?Cellular?Immunotherapy Market Forecast (2021-2026)
13.2.2 Europe Adoptive?Cellular?Immunotherapy Market Forecast (2021-2026)
13.2.3 Asia-Pacific Adoptive?Cellular?Immunotherapy Market Forecast (2021-2026)
13.2.4 South America Adoptive?Cellular?Immunotherapy Market Forecast (2021-2026)
13.2.5 Middle East & Africa Adoptive?Cellular?Immunotherapy Market Forecast (2021-2026)
13.3 Adoptive?Cellular?Immunotherapy Market Forecast by Type (2021-2026)
13.3.1 Global Adoptive?Cellular?Immunotherapy Sales Forecast by Type (2021-2026)
13.3.2 Global Adoptive?Cellular?Immunotherapy Market Share Forecast by Type (2021-2026)
13.4 Adoptive?Cellular?Immunotherapy Market Forecast by Application (2021-2026)
13.4.1 Global Adoptive?Cellular?Immunotherapy Sales Forecast by Application (2021-2026)
13.4.2 Global Adoptive?Cellular?Immunotherapy Market Share Forecast by Application (2021-2026)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Adoptive?Cellular?Immunotherapy Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Adoptive?Cellular?Immunotherapy Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures

Figure Product Picture Adoptive?Cellular?Immunotherapy
Figure Market Concentration Ratio and Market Maturity Analysis of Adoptive?Cellular?Immunotherapy
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Adoptive?Cellular?Immunotherapy Market Size by Type
Figure Global Market Share of Adoptive?Cellular?Immunotherapy by Type in 2020
Figure TIL Picture
Figure LAK Picture
Figure CAR-T Picture
Figure TCR-T Picture
Figure CIK Picture
Figure NK Picture
Figure DC Picture
Figure Other Picture
Table Global Adoptive?Cellular?Immunotherapy Market Size (Volume) by Application
Figure Hospital Picture
Figure Cancer Hospital Picture
Figure Centers for Disease Control and Prevention Picture
Figure Rehabilitation Center Picture
Figure Other Picture
Table Global Adoptive?Cellular?Immunotherapy Comparison by Regions (M USD) 2016-2026
Figure Global Adoptive?Cellular?Immunotherapy Market Size (Million US$) (2016-2026)
Figure North America Adoptive?Cellular?Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Adoptive?Cellular?Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Figure Asia-pacific Adoptive?Cellular?Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Figure South America Adoptive?Cellular?Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Figure Middle East & Africa Adoptive?Cellular?Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Adoptive?Cellular?Immunotherapy Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Adoptive?Cellular?Immunotherapy Sales by Manufacturer (2016-2021)
Figure Global Adoptive?Cellular?Immunotherapy Sales Market Share by Manufacturer in 2020
Table Global Adoptive?Cellular?Immunotherapy Revenue by Manufacturer (2016-2021)
Figure Global Adoptive?Cellular?Immunotherapy Revenue Market Share by Manufacturer in 2020
Table Global Adoptive?Cellular?Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Adoptive?Cellular?Immunotherapy Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Adoptive?Cellular?Immunotherapy Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Adoptive?Cellular?Immunotherapy Market
Table Key Manufacturers Adoptive?Cellular?Immunotherapy Product Type
Table Mergers & Acquisitions Planning
Table Amgen Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Amgen Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Amgen Inc 2016-2021
Table Amgen Inc Main Business
Table Amgen Inc Recent Development
Table Celgene Corp Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Celgene Corp
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Celgene Corp 2016-2021
Table Celgene Corp Main Business
Table Celgene Corp Recent Development
Table Bellicum Pharmaceuticals Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Bellicum Pharmaceuticals Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bellicum Pharmaceuticals Inc 2016-2021
Table Bellicum Pharmaceuticals Inc Main Business
Table Bellicum Pharmaceuticals Inc Recent Development
Table Autolus Therapeutics Plc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Autolus Therapeutics Plc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Autolus Therapeutics Plc 2016-2021
Table Autolus Therapeutics Plc Main Business
Table Autolus Therapeutics Plc Recent Development
Table CARsgen Therapeutics Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of CARsgen Therapeutics Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of CARsgen Therapeutics Ltd 2016-2021
Table CARsgen Therapeutics Ltd Main Business
Table CARsgen Therapeutics Ltd Recent Development
Table Beijing Immunochina Medical Science & Technology Co Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Beijing Immunochina Medical Science & Technology Co Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Beijing Immunochina Medical Science & Technology Co Ltd 2016-2021
Table Beijing Immunochina Medical Science & Technology Co Ltd Main Business
Table Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
Table Cellular Biomedicine Group Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Cellular Biomedicine Group Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cellular Biomedicine Group Inc 2016-2021
Table Cellular Biomedicine Group Inc Main Business
Table Cellular Biomedicine Group Inc Recent Development
Table bluebird bio Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of bluebird bio Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of bluebird bio Inc 2016-2021
Table bluebird bio Inc Main Business
Table bluebird bio Inc Recent Development
Table Bristol-Myers Squibb Co Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Bristol-Myers Squibb Co
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb Co 2016-2021
Table Bristol-Myers Squibb Co Main Business
Table Bristol-Myers Squibb Co Recent Development
Table Cell Medica Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Cell Medica Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cell Medica Ltd 2016-2021
Table Cell Medica Ltd Main Business
Table Cell Medica Ltd Recent Development
Table Gilead Sciences Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Gilead Sciences Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Gilead Sciences Inc 2016-2021
Table Gilead Sciences Inc Main Business
Table Gilead Sciences Inc Recent Development
Table Hebei Senlang Biotechnology Inc Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Hebei Senlang Biotechnology Inc Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hebei Senlang Biotechnology Inc Ltd 2016-2021
Table Hebei Senlang Biotechnology Inc Ltd Main Business
Table Hebei Senlang Biotechnology Inc Ltd Recent Development
Table Celularity Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Celularity Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Celularity Inc 2016-2021
Table Celularity Inc Main Business
Table Celularity Inc Recent Development
Table Juno Therapeutics Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Juno Therapeutics Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ju

Amgen Inc
Celgene Corp
Bellicum Pharmaceuticals Inc
Autolus Therapeutics Plc
CARsgen Therapeutics Ltd
Beijing Immunochina Medical Science & Technology Co Ltd
Cellular Biomedicine Group Inc
bluebird bio Inc
Bristol-Myers Squibb Co
Cell Medica Ltd
Gilead Sciences Inc
Hebei Senlang Biotechnology Inc Ltd
Celularity Inc
Juno Therapeutics Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Fosun Pharmaceutical AG
Celyad SA
HRAIN Biotechnology Co Ltd
Hangzhou Converd Co Ltd
Daiichi Sankyo Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Kite Pharma Inc
Ono Pharmaceutical Co Ltd
Novartis AG
Takara Bio Inc
Nkarta Inc
Nanjing Legend Biotech Co Ltd
Sorrento Therapeutics Inc
NantKwest Inc

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE